Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
- Inflectra
- Zymfentra
Descriptions
Infliximab-dyyb injection is used to reduce the symptoms of moderate to severe active Crohn's disease and ulcerative colitis in adults and children who have been previously treated with other medicines that did not work well. It is also used as a maintenance treatment for moderate to severe active Crohn's disease and ulcerative colitis after receiving an infliximab medicine given by your doctor.
Infliximab-dyyb injection is also used in combination with other medicines (eg, methotrexate) to reduce the symptoms and prevent the progression of moderate to severe active rheumatoid arthritis.
Infliximab-dyyb injection is also used to reduce the symptoms and prevent the progression of active ankylosing spondylitis. It is also used to reduce symptoms and prevent the progression of psoriatic arthritis.
Infliximab-dyyb injection is also used to treat chronic severe (extensive or disabling) plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is used in patients who may benefit from receiving other treatments. This medicine is a monoclonal antibody that works on the immune system.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
- Powder for Solution
- Solution
Portions of this document last updated: April 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.